Predicting lymph node metastasis in colorectal cancer patients: development and validation of a column chart model
- PMID: 38954377
- PMCID: PMC11341625
- DOI: 10.1007/s13304-024-01884-6
Predicting lymph node metastasis in colorectal cancer patients: development and validation of a column chart model
Abstract
Lymph node metastasis (LNM) is one of the crucial factors in determining the optimal treatment approach for colorectal cancer. The objective of this study was to establish and validate a column chart for predicting LNM in colon cancer patients. We extracted a total of 83,430 cases of colon cancer from the Surveillance, Epidemiology, and End Results (SEER) database, spanning the years 2010-2017. These cases were divided into a training group and a testing group in a 7:3 ratio. An additional 8545 patients from the years 2018-2019 were used for external validation. Univariate and multivariate logistic regression models were employed in the training set to identify predictive factors. Models were developed using logistic regression, LASSO regression, ridge regression, and elastic net regression algorithms. Model performance was quantified by calculating the area under the ROC curve (AUC) and its corresponding 95% confidence interval. The results demonstrated that tumor location, grade, age, tumor size, T stage, race, and CEA were independent predictors of LNM in CRC patients. The logistic regression model yielded an AUC of 0.708 (0.7038-0.7122), outperforming ridge regression and achieving similar AUC values as LASSO regression and elastic net regression. Based on the logistic regression algorithm, we constructed a column chart for predicting LNM in CRC patients. Further subgroup analysis based on gender, age, and grade indicated that the logistic prediction model exhibited good adaptability across all subgroups. Our column chart displayed excellent predictive capability and serves as a useful tool for clinicians in predicting LNM in colorectal cancer patients.
Keywords: Colorectal cancer; Lymphatic metastasis; Nomogram; SEER; Treatment programs.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Establishment and Validation for Predicting the Lymph Node Metastasis in Early Gastric Adenocarcinoma.J Healthc Eng. 2022 Jun 29;2022:8399822. doi: 10.1155/2022/8399822. eCollection 2022. J Healthc Eng. 2022. PMID: 35812896 Free PMC article.
-
Incidence, risk factors, and a predictive model for lymph node metastasis of submucosal (T1) colon cancer: A population-based study.J Dig Dis. 2019 Jun;20(6):288-293. doi: 10.1111/1751-2980.12754. Epub 2019 May 26. J Dig Dis. 2019. PMID: 31021492
-
Preoperative inflammatory markers and tumor markers in predicting lymphatic metastasis and postoperative complications in colorectal cancer: a retrospective study.BMC Surg. 2025 Feb 18;25(1):71. doi: 10.1186/s12893-025-02795-y. BMC Surg. 2025. PMID: 39966788 Free PMC article.
-
LASSO-derived nomogram prediction model for lymph node metastasis in colorectal cancer: a retrospective analysis.PeerJ. 2025 Apr 14;13:e19148. doi: 10.7717/peerj.19148. eCollection 2025. PeerJ. 2025. PMID: 40247833 Free PMC article.
-
Application of machine learning for predicting lymph node metastasis in T1 colorectal cancer: a systematic review and meta-analysis.Langenbecks Arch Surg. 2024 Sep 23;409(1):287. doi: 10.1007/s00423-024-03476-9. Langenbecks Arch Surg. 2024. PMID: 39311932
Cited by
-
Factors associated with lymph node metastasis and survival in T2 colon cancer.BMC Gastroenterol. 2025 Mar 14;25(1):175. doi: 10.1186/s12876-025-03748-8. BMC Gastroenterol. 2025. PMID: 40087580 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical